| 1 |
25868784 | Silibinin combination with arsenic strongly inhibits survival and invasiveness of human prostate carcinoma cells. | 2015 |
1 |
| 2 |
19908243 | Silibinin inhibits human nonsmall cell lung cancer cell growth through cell-cycle arrest by modulating expression and function of key cell-cycle regulators. | 2010 Mar |
1 |
| 3 |
19147767 | Silibinin suppresses growth of human prostate carcinoma PC-3 orthotopic xenograft via activation of extracellular signal-regulated kinase 1/2 and inhibition of signal transducers and activators of transcription signaling. | 2009 Jan 15 |
1 |
| 4 |
16322307 | Silibinin efficacy against human hepatocellular carcinoma. | 2005 Dec 1 |
2 |
| 5 |
14614451 | Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. | 2003 Nov 13 |
2 |
| 6 |
12429923 | The cancer preventive flavonoid silibinin causes hypophosphorylation of Rb/p107 and Rb2/p130 via modulation of cell cycle regulators in human prostate carcinoma DU145 cells. | 2002 Mar-Apr |
1 |
| 7 |
12479270 | Inhibition of retinoblastoma protein (Rb) phosphorylation at serine sites and an increase in Rb-E2F complex formation by silibinin in androgen-dependent human prostate carcinoma LNCaP cells: role in prostate cancer prevention. | 2002 May |
1 |
| 8 |
11759294 | Differential responses of skin cancer-chemopreventive agents silibinin, quercetin, and epigallocatechin 3-gallate on mitogenic signaling and cell cycle regulators in human epidermoid carcinoma A431 cells. | 2001 |
1 |
| 9 |
10377442 | Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention. | 1999 Jun 22 |
2 |